We are dedicated to meeting our client’s expectations and provide the highest level of service to create overall value for our partners. Our team has an extensive experience in this field. Our managers participated in the Clinical Proteomics Tumor Analysis Consortium (CPTAC) Project and The Cancer Genome Atlas (TCGA) Project by the National Cancer Institute, USA.
• Estimated accrual rate based on your collection needs
• Evaluation of the project feasibility, specifications and protocols
• Development of SOPs (if necessary)
• Management of IRB/ IEC submission process
• Selection and qualification of the clinical sites
• Project implementation and monitoring at the clinical site(s)
• Quality control of the collected samples
• Organization of the sample’s storage and delivery to the client
• Conducting of internal audit of the clinical sites
• Preservation and processing of fresh tissues (preparation of FFPE, FF, PAXgene, RNAlater-preserved tissues; isolation of PBMCs; preparation of plasma, serum, etc.)
• DNA/RNA isolation
• Fresh tissue dissociation and isolation of viable cells, including isolation of tumor-infiltrating lymphocytes (TILs) from fresh tumor specimens
• Screening for gene mutations